We are live on
!
Find out more
ACM
AlphaCrest Capital Management Portfolio holdings
AUM
$1.64B
1-Year Est. Return
23.4%
This Fund
S&P 500
This Quarter
Est. Return
-7.05%
1 Year Est. Return
-23.4%
3 Year Est. Return
-8.44%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.64B
AUM Growth
-$431M
(-21%)
Cap. Flow
-$291M
Cap. Flow
% of AUM
-17.73%
Top 10 Holdings %
Top 10 Hldgs %
4.35%
Holding
1,432
New
196
Increased
495
Reduced
565
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Tower
AMT
|
+$8.3M |
| 2 |
US Bancorp
USB
|
+$8.26M |
| 3 |
Sysco
SYY
|
+$5.67M |
| 4 |
Realty Income
O
|
+$5.32M |
| 5 |
Coca-Cola
KO
|
+$5.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$17.9M |
| 2 |
Electronic Arts
EA
|
+$14M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$11M |
| 4 |
JPMorgan Chase
JPM
|
+$10.9M |
| 5 |
Amgen
AMGN
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.02% |
| 2 | Financials | 16.14% |
| 3 | Healthcare | 13.06% |
| 4 | Industrials | 12.93% |
| 5 | Consumer Discretionary | 11.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Baker Hughes
BKR
$60.1B
| $287K | 0.02% |
13,714
-4,660
| -25% | -$117K |
|
1152
Fate Therapeutics
FATE
$283M
| $287K | 0.02% |
+12,823
| New | +$371K |
|
1153
Yeti Holdings
YETI
$3.86B
| $286K | 0.02% |
+10,021
| New | +$418K |
|
1154
SM Energy
SM
$7.26B
| $285K | 0.02% |
7,577
-3,748
| -33% | -$147K |
|
|
SMAR
1155
DELISTED
Smartsheet Inc.
SMAR
| $284K | 0.02% |
8,259
-9,148
| -53% | -$310K |
|
1156
ABM Industries
ABM
$2.84B
| $283K | 0.02% |
7,393
-4,989
| -40% | -$218K |
|
1157
Reinsurance Group of America
RGA
$15.7B
| $283K | 0.02% |
2,251
-1,835
| -45% | -$226K |
|
1158
Timken Company
TKR
$9.81B
| $282K | 0.02% |
4,775
-18,158
| -79% | -$1.13M |
|
1159
Cactus
WHD
$3.74B
| $282K | 0.02% |
+7,350
| New | +$295K |
|
1160
Paylocity
PCTY
$6.97B
| $281K | 0.02% |
1,165
-1,794
| -61% | -$412K |
|
1161
Axsome Therapeutics
AXSM
$12.3B
| $280K | 0.02% |
+6,268
| New | +$313K |
|
|
LPRO
1162
Open Lending Corp
LPRO
$372M
| $280K | 0.02% |
34,798
-32,547
| -48% | -$329K |
|
|
ATSG
1163
DELISTED
Air Transport Services Group
ATSG
| $280K | 0.02% |
+11,613
| New | +$337K |
|
1164
Cytokinetics
CYTK
$10.9B
| $279K | 0.02% |
+5,763
| New | +$277K |
|
1165
Nutrien
NTR
$32.4B
| $279K | 0.02% |
+3,347
| New | +$288K |
|
1166
Ryman Hospitality Properties
RHP
$8.52B
| $279K | 0.02% |
+3,790
| New | +$317K |
|
1167
Healthcare Services Group
HCSG
$1.58B
| $274K | 0.02% |
22,654
-1,890
| -8% | -$27.9K |
|
1168
Charles River Laboratories
CRL
$10.8B
| $273K | 0.02% |
1,388
+416
| +43% | +$89.8K |
|
1169
CarMax
KMX
$8.29B
| $273K | 0.02% |
4,140
-24,437
| -86% | -$2.23M |
|
1170
Coursera
COUR
$1.61B
| $270K | 0.02% |
+25,073
| New | +$332K |
|
1171
IPG Photonics
IPGP
$3.81B
| $270K | 0.02% |
3,196
-12,555
| -80% | -$1.19M |
|
1172
Insperity
NSP
$1.92B
| $270K | 0.02% |
2,647
-19,312
| -88% | -$2.07M |
|
|
JAMF
1173
DELISTED
Jamf
JAMF
| $267K | 0.02% |
+12,062
| New | +$298K |
|
1174
Kimco Realty
KIM
$17.8B
| $267K | 0.02% |
14,528
-4,804
| -25% | -$101K |
|
1175
Leslie's
LESL
$10.8M
| $264K | 0.02% |
+897
| New | +$269K |
|
Similar funds
RHBC
BDF
SCA
IC
WFA
CA
RIG
CCP
AlphaCrest Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, AlphaCrest Capital Management held 1,432 positions worth $1.64B, down 21% from $2.07B the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
AlphaCrest Capital Management withdrew a net $291M in Q3 2022, closing 176 positions and reducing 565 holdings. Its most notable exit was Stryker, an estimated $7.96M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, AlphaCrest Capital Management opened a new position in AT&T worth $3.27M.
- AlphaCrest Capital Management's largest Q3 2022 buy was AT&T: 212,810 shares worth $3.27M.
- AlphaCrest Capital Management added most to American Tower in Q3 2022, an estimated $8.3M increase.
- AlphaCrest Capital Management's biggest Q3 2022 reduction was Target, cutting an estimated $17.9M.
- AlphaCrest Capital Management fully exited Stryker in Q3 2022, selling an estimated $7.96M.
- AlphaCrest Capital Management's ten largest holdings make up 4.4% of its $1.64B portfolio in Q3 2022.
- AlphaCrest Capital Management opened 196 new positions and closed 176 in Q3 2022.
- AlphaCrest Capital Management's portfolio value fell 21% quarter-over-quarter to $1.64B.
Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.